The global Transcatheter Heart Valve Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), By Technology (Balloon Expanded Transcatheter Valve, Self-Expanded Transcatheter Valve).
The transcatheter heart valve market is witnessing significant growth in 2024, driven by advancements in structural heart interventions, transcatheter aortic valve replacement (TAVR) procedures, and the increasing prevalence of valvular heart diseases, leading to greater demand for minimally invasive valve replacement options for high-risk and elderly patients. Transcatheter heart valves encompass a variety of transcatheter aortic valves, transcatheter mitral valves, and transcatheter pulmonary valves delivered through catheter-based delivery systems, enabling percutaneous valve implantation, valve repair, and valve-in-valve procedures for patients with aortic stenosis, mitral regurgitation, or congenital heart defects, offering reduced morbidity, shorter hospital stays, and improved clinical outcomes compared to traditional open heart surgeries. With innovations in valve design, delivery systems, and procedural techniques, the market is experiencing rapid expansion and adoption of transcatheter heart valves, offering cardiac surgeons, interventional cardiologists, and structural heart specialists innovative and patient-specific solutions for valve replacement, valve repair, and valve-in-valve interventions, driving advancements in minimally invasive cardiac interventions and transcatheter valve therapies.
A significant trend in the transcatheter heart valve market is the increasing adoption of transcatheter aortic valve replacement (TAVR) procedures as a less invasive alternative to surgical aortic valve replacement (SAVR). TAVR procedures involve the percutaneous delivery of a collapsible valve through a catheter, typically inserted via the femoral artery, to replace a diseased aortic valve. This trend is fueled by advancements in device technology, procedural techniques, and patient selection criteria, enabling TAVR to be performed in a broader range of patients, including those deemed high-risk or inoperable for SAVR. As healthcare systems prioritize minimally invasive approaches for heart valve interventions, the demand for transcatheter heart valves continues to grow, supporting market expansion and innovation.
The aging population and the growing prevalence of valvular heart diseases, such as aortic stenosis and mitral regurgitation, serve as significant drivers for the transcatheter heart valve market. Valvular heart diseases are common among the elderly and are associated with significant morbidity and mortality if left untreated. Transcatheter heart valves offer a less invasive treatment option for patients who are at high risk or ineligible for traditional surgical valve replacement procedures. As the global population ages and the burden of valvular heart diseases continues to increase, there is a rising demand for transcatheter heart valves to address the unmet clinical needs of patients, driving market growth and adoption.
The expansion of transcatheter heart valves into the realm of transcatheter mitral valve replacement (TMVR) represents a promising opportunity for market growth. Mitral valve disease, including mitral stenosis and mitral regurgitation, poses significant challenges in treatment, particularly among patients who are deemed high-risk or ineligible for conventional mitral valve surgery. TMVR procedures aim to replace the diseased mitral valve using transcatheter techniques, offering a less invasive alternative to open-heart surgery. While TMVR is still in the early stages of development and clinical evaluation, there is growing interest and investment in this field, driven by the potential to address a large unmet need in the treatment of mitral valve disease. Capitalizing on this opportunity requires continued innovation in device design, procedural techniques, and clinical evidence generation to advance TMVR technologies and expand market adoption in the evolving landscape of transcatheter heart valve interventions.
By Application
Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve
By Technology
Balloon Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Boston Scientific Corp
Bracco Group
Braile Biomedica
Direct Flow Medical
Edwards Lifesciences
JenaValve
St. Jude Medical
Symetis
ValveXchange Inc
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Transcatheter Heart Valve Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Transcatheter Heart Valve Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Transcatheter Heart Valve Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Transcatheter Heart Valve Market Size Outlook, $ Million, 2021 to 2030
3.2 Transcatheter Heart Valve Market Outlook by Type, $ Million, 2021 to 2030
3.3 Transcatheter Heart Valve Market Outlook by Product, $ Million, 2021 to 2030
3.4 Transcatheter Heart Valve Market Outlook by Application, $ Million, 2021 to 2030
3.5 Transcatheter Heart Valve Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Transcatheter Heart Valve Industry
4.2 Key Market Trends in Transcatheter Heart Valve Industry
4.3 Potential Opportunities in Transcatheter Heart Valve Industry
4.4 Key Challenges in Transcatheter Heart Valve Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Transcatheter Heart Valve Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Transcatheter Heart Valve Market Outlook by Segments
7.1 Transcatheter Heart Valve Market Outlook by Segments, $ Million, 2021- 2030
By Application
Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve
By Technology
Balloon Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
8 North America Transcatheter Heart Valve Market Analysis and Outlook To 2030
8.1 Introduction to North America Transcatheter Heart Valve Markets in 2024
8.2 North America Transcatheter Heart Valve Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Transcatheter Heart Valve Market size Outlook by Segments, 2021-2030
By Application
Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve
By Technology
Balloon Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
9 Europe Transcatheter Heart Valve Market Analysis and Outlook To 2030
9.1 Introduction to Europe Transcatheter Heart Valve Markets in 2024
9.2 Europe Transcatheter Heart Valve Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Transcatheter Heart Valve Market Size Outlook by Segments, 2021-2030
By Application
Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve
By Technology
Balloon Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
10 Asia Pacific Transcatheter Heart Valve Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Transcatheter Heart Valve Markets in 2024
10.2 Asia Pacific Transcatheter Heart Valve Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Transcatheter Heart Valve Market size Outlook by Segments, 2021-2030
By Application
Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve
By Technology
Balloon Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
11 South America Transcatheter Heart Valve Market Analysis and Outlook To 2030
11.1 Introduction to South America Transcatheter Heart Valve Markets in 2024
11.2 South America Transcatheter Heart Valve Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Transcatheter Heart Valve Market size Outlook by Segments, 2021-2030
By Application
Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve
By Technology
Balloon Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
12 Middle East and Africa Transcatheter Heart Valve Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Transcatheter Heart Valve Markets in 2024
12.2 Middle East and Africa Transcatheter Heart Valve Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Transcatheter Heart Valve Market size Outlook by Segments, 2021-2030
By Application
Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve
By Technology
Balloon Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Boston Scientific Corp
Bracco Group
Braile Biomedica
Direct Flow Medical
Edwards Lifesciences
JenaValve
St. Jude Medical
Symetis
ValveXchange Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Application
Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve
By Technology
Balloon Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve
The global Transcatheter Heart Valve Market is one of the lucrative growth markets, poised to register a 16.3% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Boston Scientific Corp, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis, ValveXchange Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume